- Nivolumab Plus Ipilimumab Demonstrates Anti-Tumor Activity in Metastatic Castration-Resistant Prostate Cancer
The combination of nivolumab (Opdivo) plus ipilimumab (Yervoy) demonstrated significant anti-tumor activity when treating patients with metastatic castration-resistant prostate cancer (mCRPC) and immunogenic signature, according to data presented at the virtual AACR Annual Meeting 2021.
- Digital COVID-19 Vaccine Record
- John Darnielle Wants to Tell You a Story
The Mountain Goats front man and novelist discusses art as labor, the value of religious faith, the beauty of Chaucer, and, more or less, the secret to happiness.
Digest powered by RSS Digest
0 comments ↓
There are no comments yet...Kick things off by filling out the form below.
You must log in to post a comment.